OptiBiotix Health (LON:OPTI) Releases Quarterly Earnings Results

Posted by Brenda Bartman on Sep 18th, 2026

OptiBiotix Health (LON:OPTI – Get Free Report) announced its quarterly earnings results on Thursday. The company reported GBX (1.52) EPS for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%.

OptiBiotix Health Price Performance

OPTI stock remained flat at GBX 5.95 during midday trading on Friday. 580,627 shares of the company’s stock were exchanged, compared to its average volume of 359,691. The firm has a 50 day moving average price of GBX 5.79 and a 200-day moving average price of GBX 5.73. OptiBiotix Health has a 1-year low of GBX 4.50 and a 1-year high of GBX 12.25. The stock has a market capitalization of £6.15 million, a price-to-earnings ratio of -1.55 and a beta of 1.82.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.